Medicine · HIV/AIDS and Infections (Dengue, COVID-19, Opportunistic Infections)

A patient with HIV and CD4 40 cells/µL develops headache and papilledema. CSF India ink preparation shows encapsulated yeasts. Initial antifungal therapy for cryptococcal meningitis should include:

  • A Fluconazole 400 mg/day for 8 weeks
  • B Voriconazole 200 mg twice daily
  • C Liposomal amphotericin B + flucytosine for 2 weeks (induction phase)
  • D Itraconazole 200 mg twice daily
Correct answer: C. Liposomal amphotericin B + flucytosine for 2 weeks (induction phase)

Explanation

WHO and IDSA guidelines for HIV-associated cryptococcal meningitis recommend a 3-phase approach: induction (liposomal/conventional amphotericin B + flucytosine for 2 weeks), consolidation (fluconazole 400 mg/day for 8 weeks), and maintenance (fluconazole 200 mg/day for ≥1 year until CD4 > 200 cells/µL on ART). The ACTA trial confirmed amphotericin B + flucytosine superiority over fluconazole-based induction in reducing 10-week mortality. Serial lumbar punctures for ICP management are also critical as elevated CSF pressure is the primary cause of early death. Fluconazole monotherapy induction is inferior.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More HIV/AIDS and Infections (Dengue, COVID-19, Opportunistic Infections) MCQs

See all HIV/AIDS and Infections (Dengue, COVID-19, Opportunistic Infections) MCQs →